SEC Comment Letter for Sanara MedTech Inc. (SMTI) (CIK 0000714256) (SMTI) — Dec 30, 2020
Sanara MedTech Inc. (SMTI) (CIK 0000714256)
Date: Dec. 30, 2020 · CIK: 0000714256 · Accession: 0000000000-20-012592
AI Filing Summary & Sentiment
File numbers found in text: 333-251652
Letter
United States securities and exchange commission logo December 30, 2020 Michael D. McNeil Chief Financial Officer Sanara MedTech Inc. 1200 Summit Ave, Suite 414 Fort Worth, Texas 76102 Re:Sanara MedTech Inc. Registration Statement on Form S-3 Filed December 23, 2020 File No. 333-251652 Dear Mr. McNeil: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew L. Fry, Esq.
Show Raw Text
United States securities and exchange commission logo
December 30, 2020
Michael D. McNeil
Chief Financial Officer
Sanara MedTech Inc.
1200 Summit Ave, Suite 414
Fort Worth, Texas 76102
Re:Sanara MedTech Inc.
Registration Statement on Form S-3
Filed December 23, 2020
File No. 333-251652
Dear Mr. McNeil:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Matthew L. Fry, Esq.